NEW YORK--(BUSINESS WIRE)--Pluristem Therapeutics Inc. (NasdaqCM:PSTI) (DAX:PJT), a bio-therapeutics company dedicated to the commercialization of unrelated donor-patient (allogeneic) cell therapy products for a variety of disorders, announced today that Edwin M. Horwitz, MD, PhD, Chairman of Pluristem’s Scientific Advisory Board, has been invited to present at the 19th Israeli Medical Association (IMA) World Fellowship International Conference in Tel Aviv, Israel on Wednesday April 22, 2009. Dr. Horwitz’s presentation is entitled “Cytokines as the Major Mechanism of MSC Clinical Activity: Expanding the Spectrum of Cell Therapy.”
